Clinical Trial Update: A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

View source ↗

Summary

Completed clinical trial evaluating Lumigan 0.01% in primary open-angle glaucoma or ocular hypertension has posted results (2014-06-13).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Ocular Hypertension

Drugs mentioned

• Lumigan (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Status: COMPLETED | Results posted: 2014-06-13